Beckman Coulter, Inc.

Clinical trials sponsored by Beckman Coulter, Inc., explained in plain language.

Now part of Danaher Corporation DHR NYSE

A diagnostics company providing laboratory instruments and reagents.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Not yet finished but already full! 1 Completed 2 Terminated 1

Heart attack predictor in the works, but study halted before start

Knowledge-focused Cancelled

This study aimed to gather real-world health records to help build a computer tool that predicts a person's risk of a major heart event within 30 days. The tool would use one or two high-sensitivity troponin blood tests. The study was withdrawn before enrolling any participants, …

Sponsor: Beckman Coulter, Inc. • Aim: Knowledge-focused

Last updated Jun 27, 2026 07:57 UTC

Beckman Coulter, Inc.

Heart attack predictor in the works, but study halted before start